Ledyard National Bank Regeneron Pharmaceuticals, Inc. Transaction History

Ledyard National Bank

$1.09 Billion
Q3 2024

A detailed history of Ledyard National Bank transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ledyard National Bank holds 6,391 shares of REGN stock, worth $4.49 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

6,391

Previous 6,581 2.89%

Holding current value

$4.49 Million

Previous $6.92 Million 2.86%

% of portfolio

0.62%

Previous 0.67%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$1024.09 - $1201.76 $194,577 - $228,334	-190 Reduced 2.89%	6,391 $6.72 Million
Q2 2024 Aug 05, 2024	SELL	$883.2 - $1071.19 $353,280 - $428,476	-400 Reduced 5.73%	6,581 $6.92 Million
Q1 2024 May 08, 2024	SELL	$902.69 - $993.35 $409,821 - $450,980	-454 Reduced 6.11%	6,981 $6.72 Million
Q4 2023 Feb 05, 2024	SELL	$775.18 - $881.7 $153,485 - $174,576	-198 Reduced 2.59%	7,435 $6.53 Million
Q3 2023 Nov 07, 2023	SELL	$692.45 - $844.37 $83,094 - $101,324	-120 Reduced 1.55%	7,633 $6.28 Million
Q2 2023 Aug 09, 2023	SELL	$700.03 - $830.35 $194,608 - $230,837	-278 Reduced 3.46%	7,753 $5.57 Million
Q1 2023 Apr 25, 2023	SELL	$680.49 - $826.97 $228,644 - $277,861	-336 Reduced 4.02%	8,031 $6.6 Million
Q4 2022 Feb 06, 2023	SELL	$705.89 - $766.39 $372,709 - $404,653	-528 Reduced 5.94%	8,367 $6.04 Million
Q3 2022 Oct 18, 2022	SELL	$573.97 - $724.32 $177,930 - $224,539	-310 Reduced 3.37%	8,895 $6.13 Million
Q2 2022 Jul 19, 2022	SELL	$548.35 - $738.84 $193,567 - $260,810	-353 Reduced 3.69%	9,205 $5.44 Million
Q1 2022 Apr 25, 2022	BUY	$595.12 - $698.43 $80,936 - $94,986	136 Added 1.44%	9,558 $6.68 Million
Q4 2021 Jan 31, 2022	BUY	$543.48 - $670.97 $813,046 - $1 Million	1,496 Added 18.87%	9,422 $5.95 Million
Q3 2021 Oct 20, 2021	SELL	$574.03 - $680.96 $94,714 - $112,358	-165 Reduced 2.04%	7,926 $4.8 Million
Q2 2021 Jul 27, 2021	BUY	$472.8 - $558.54 $69,501 - $82,105	147 Added 1.85%	8,091 $4.52 Million
Q1 2021 Apr 27, 2021	BUY	$446.73 - $548.2 $166,183 - $203,930	372 Added 4.91%	7,944 $3.76 Million
Q4 2020 Jan 25, 2021	BUY	$478.3 - $607.98 $2.7 Million - $3.43 Million	5,641 Added 292.13%	7,572 $3.66 Million
Q3 2020 Oct 21, 2020	SELL	$544.75 - $658.21 $29,416 - $35,543	-54 Reduced 2.72%	1,931 $1.08 Million
Q2 2020 Jul 24, 2020	SELL	$493.32 - $643.92 $27,625 - $36,059	-56 Reduced 2.74%	1,985 $1.24 Million
Q1 2020 Apr 24, 2020	SELL	$336.18 - $494.43 $29,247 - $43,015	-87 Reduced 4.09%	2,041 $997,000
Q4 2019 Jan 31, 2020	SELL	$274.13 - $376.51 $1.19 Million - $1.64 Million	-4,357 Reduced 67.19%	2,128 $799,000
Q3 2019 Oct 23, 2019	SELL	$273.46 - $318.39 $170,912 - $198,993	-625 Reduced 8.79%	6,485 $1.8 Million
Q2 2019 Jul 26, 2019	SELL	$299.6 - $414.82 $734,918 - $1.02 Million	-2,453 Reduced 25.65%	7,110 $2.23 Million
Q1 2019 Apr 12, 2019	BUY	$372.08 - $439.57 $3.47 Million - $4.1 Million	9,323 Added 3884.58%	9,563 $3.93 Million
Q4 2018 Jan 29, 2019	BUY	$335.82 - $403.04 $80,596 - $96,729	240 New	240 $90,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ledyard National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Ledyard National Bank with notifications on news.

Account

Ledyard National Bank Regeneron Pharmaceuticals, Inc. Transaction History